20. Adrenoleukodystrophy
49 clinical trials,   86 drugs   (DrugBank: 29 drugs),   18 drug target genes,   112 drug target pathways

Searched query = "Adrenoleukodystrophy", "Adrenomyeloneuropathy", "AMN"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00004450
(ClinicalTrials.gov)
August 199818/10/1999Randomized Study of Beta Interferon and Thalidomide in Patients With AdrenoleukodystrophyAdrenoleukodystrophyDrug: glyceryl trierucate;Drug: glyceryl trioleate;Drug: interferon beta;Drug: thalidomideFDA Office of Orphan Products DevelopmentHugo W. Moser Research Institute at Kennedy Krieger, Inc.Completed4 YearsN/AMale60N/ANULL
2NCT00004418
(ClinicalTrials.gov)
April 199818/10/1999Effect of Glycerol Trierucate on Clinical Course of AdrenoleukodystrophyStudy of Glyceryl Trierucate and Glyceryl Trioleate (Lorenzo's Oil) Therapy in Male Children With AdrenoleukodystrophyAdrenoleukodystrophyDrug: glyceryl trierucate/glyceryl trioleateHugo W. Moser Research Institute at Kennedy Krieger, Inc.NULLTerminated18 Months8 YearsMale126Phase 2United States